Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Current Liabilities (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Total Current Liabilities readings, the most recent being $1.2 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 25.68% to $1.2 million in Q1 2026 year-over-year; TTM through Feb 2026 was $1.2 million, a 25.68% increase, with the full-year FY2025 number at $945963.0, up 7.26% from a year prior.
  • Total Current Liabilities reached $1.2 million in Q1 2026 per CBIH's latest filing, up from $1.1 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $1.2 million in Q1 2026, with the low at $385547.0 in Q2 2023.
  • A 4-year average of $885479.5 and a median of $881909.0 in 2024 define the central range for Total Current Liabilities.
  • Year-over-year, Total Current Liabilities skyrocketed 128.74% in 2024 and then grew 7.26% in 2025.
  • Year by year, Total Current Liabilities stood at $660307.0 in 2023, then surged by 32.16% to $872674.0 in 2024, then surged by 30.15% to $1.1 million in 2025, then grew by 7.34% to $1.2 million in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Total Current Liabilities are $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025).